Brian Werth

Brian Werth is an Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy. His work bridges clinical pharmacy and translational research, with a focus on infectious diseases and antimicrobial resistance. He has been a faculty member since 2013, following advanced training in infectious diseases pharmacotherapy.

Education:

• PharmD, University of New Mexico
• Pharmacy Practice Residency, The Queen’s Medical Center, Honolulu, HI
• Infectious Diseases Pharmacotherapy Fellowship, Wayne State University, Detroit, MI

Research Interests:

Dr. Werth’s research is centered on the mechanisms of antimicrobial resistance, particularly in Methicillin-Resistant Staphylococcus aureus (MRSA). His lab investigates how antibiotics like glycopeptides, lipopeptides, and lipoglycopeptides interact with bacterial membranes and how resistance evolves through cross-resistance and synergy. His translational approach integrates pharmacokinetics and pharmacodynamics to inform clinical therapy.

Recent Research Trends:

His recent publications reflect a strong emphasis on antibiotic synergy, resistance evolution, and global antimicrobial use surveillance. Studies span from molecular mechanisms of resistance in MRSA to national antimicrobial consumption patterns in Tanzania, highlighting both bench-to-bedside and global health perspectives.

Scientific Contributions:

While no formal awards are listed, Dr. Werth’s work is widely cited and contributes to international guidelines and policy discussions on antimicrobial use and resistance. His collaborative research includes partnerships across multiple institutions and countries.

Teaching & Mentorship:

He teaches PHRMCY 533: Pharmacotherapeutics III, covering cardiovascular, pulmonary, renal, and endocrine disorders. His mentorship includes training graduate students and fellows in translational antimicrobial research.

Labs & Teams:

Dr. Werth is affiliated with the University of Washington School of Pharmacy and collaborates with interdisciplinary teams across infectious disease pharmacotherapy, lipidomics, and global health research.